These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 18413831

  • 1. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T, Konkimalla VB, Wang YF, Sauerbrey A, Meinhardt S, Zintl F, Mattern J, Volm M.
    Clin Cancer Res; 2008 Apr 15; 14(8):2405-12. PubMed ID: 18413831
    [Abstract] [Full Text] [Related]

  • 2. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr 15; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 4. Microarray-based expression of DNA repair genes does not correlate with growth inhibition of cancer cells by natural products derived from traditional Chinese medicine.
    Konkimalla VS, Wang G, Kaina B, Efferth T.
    Cancer Genomics Proteomics; 2008 Apr 15; 5(2):79-84. PubMed ID: 18460736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance.
    Saeed M, Khalid H, Sugimoto Y, Efferth T.
    Phytomedicine; 2014 Apr 15; 21(5):689-96. PubMed ID: 24556122
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.
    Volm M.
    Behring Inst Mitt; 1984 May 15; (74):273-84. PubMed ID: 6383325
    [Abstract] [Full Text] [Related]

  • 13. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD, Işeri OD, Gunduz U, Molnar J.
    Chemotherapy; 2008 May 15; 54(3):194-200. PubMed ID: 18560226
    [Abstract] [Full Text] [Related]

  • 14. Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome.
    Scotlandi K, Remondini D, Castellani G, Manara MC, Nardi F, Cantiani L, Francesconi M, Mercuri M, Caccuri AM, Serra M, Knuutila S, Picci P.
    J Clin Oncol; 2009 May 01; 27(13):2209-16. PubMed ID: 19307502
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.